High-resolution three-dimensional MR angiography of rodent tumors: Morphologic characterization of intratumoral vasculature

Journal of Magnetic Resonance Imaging

Volumn 18, Issue 1, 2003, Pages 59-65

  Fink, Christian ^a   Kiessling, Fabian ^a   Bock, Michael ^a   Lichy, Matthias Philipp ^a   Misselwitz, Bernd ^b   Peschke, Peter ^a   Fusenig, Norbert E ^a   Grobholz, Rainer ^c   Delorme, Stefan ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b BAYER PHARMA AG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiogenesis; Blood pool contrast agents; Contrast enhanced MRA; Magnetic resonance imaging; Neoplasms

Indexed keywords

CONTRAST MEDIUM; GADOMER 17;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; IMAGE ANALYSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CARCINOMA; SIGNAL NOISE RATIO; SKIN CARCINOMA; THREE DIMENSIONAL IMAGING; TUMOR VASCULARIZATION;

ANIMALS; CONTRAST MEDIA; GADOLINIUM; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; RATS; SKIN NEOPLASMS;

EID: 0037773130     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.10318     Document Type: Article

References (30)

1. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.
2. Folkman J. Angiogenesis-dependent diseases. Semin Oncol 2001;28:536-542.
3. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
4. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-1186.
5. Folkman J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 1972;175:409-416.
6. Kerbel RS. Clinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial results. J Clin Oncol 2001;19 Suppl:45-51.
7. Brekken RA, Overholser JP, Stastny VA, Waltenberger J, Minna JD, Thorpe PE. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice. Cancer Res 2000;60:5117-5124.
8. Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res 2000;60:6737-6743.
9. Klement G, Baruchel S, Rak J, et al. Continous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J Clin Invest 2000;105:15-24.
10. Brasch R, Pham C, Shames D, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997;7:68-74.
11. Pearlman JD, Hibberd MG, Chuang ML, et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1995;1:1085-1089.
12. van Dijke CF, Brasch RC, Roberts TP, et al. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 1996;198:813-818.
13. Verhoye M, van der Sanden BP, Rijken PF, et al. Assessment of the neovascular permeability in glioma xenografts by dynamic T(1) MRI with Gadomer-17. Magn Reson Med 2002;47:305-313.
14. Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995;33:506-514.
15. Fusenig NE, Boukamp P. Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol Carcinog 1998;23:144-158.
16. Mueller MM, Peter W, Mappes M, et al. Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Am J Pathol 2001;159:1567-1579.
17. Delorme S, Peschke P, Zuna I, Van Kaick G. Sensitivity of color Doppler sonography: an experimental approach. Ultrasound Med Biol 1999;25:541-547.
18. Misselwitz B, Schmitt-Willich H, Ebert W, Frenzel T, Welnmann HJ. Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent. MAGMA 2001;12:128-134.
19. Dong Q, Hurst DR, Weinmann HJ, Chenevert TL, Londy FJ, Prince MR. Magnetic resonance angiography with Gadomer-17. An animal study original investigation. Invest Radiol 1998;33:699-708.
20. Li D, Zheng J, Weinmann HJ. Contrast-enhanced MR imaging of coronary arteries: comparison of intra- and extravascular contrast agents in swine. Radiology 2001;218:670-678.
21. Clarke SE, Weinmann HJ, Dai E, Lucas AR, Rutt BK. Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits. Radiology 2000;214:787-794.
22. Skobe M, Rockwell P, Goldstein N, Vosseler S, Fusenig NE. Halting anglogenesis suppresses carcinoma cell invasion. Nat Med. 1997;3:1222-1227.
23. Kobayashi H, Kawamoto S, Saga T, et al. Micro-MR angiography of normal and intratumoral vessels in mice using dedicated intravascular MR contrast agents with high generation of polyamidoamine dendrimer core: reference to pharmacokinetic properties of dendrimer-based MR contrast agents. J Magn Reson Imaging 2001;14:705-713.
24. Kobayashi H, Sato N, Kawamoto S, et al. 3D MR angiography of intratumoral vasculature using a novel macromolecular MR contrast agent. Magn Reson Med 2001;46:579-585.
25. Kobayashi H, Shirakawa K, Kawamoto S, et al. Rapid accumulation and internalization of radiolabeled herceptin in an inflammatory breast cancer xenograft with vasculogenic mimicry predicted by the contrast-enhanced dynamic MRI with the macromolecular contrast agent G6-(1B4M-Gd)(256). Cancer Res 2002;62:860-866.
26. Schwickert HC, Stiskal M, van Dijke CF, et al. Tumor angiography using high-resolution, three-dimensional magnetic resonance imaging: comparison of gadopentetate dimeglumine and a macromolecular blood-pool contrast agent. Acad Radiol 1995;2:851-858.
27. Johnson GA, Cofer GP, Gewalt SL, Hedlund LW. Morphologic phenotyping with MR microscopy: the visible mouse. Radiology 2002;222:789-793.
28. Abduljalil AM, Robitaille PM. Macroscopic susceptibility in ultra high field MRI. J Comput Assist Tomogr 1999;23:832-841.
29. Kroft LJ, de Roos A. Blood pool contrast agents for cardiovascular MR imaging. J Magn Reson Imaging 1999;10:395-403.
30. Burns PN, Powers JE, Hope Simpson D, et al. Harmonic power mode Doppler using microbubble contrast agents: an improved method for small vessel flow imaging. In: Proceedings of the IEEE Ultrasonics Symposium, Cannes, France. 1994;1547-1550.